During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor antagonist for patients with Tourette syndrome. Emalex Biosciences announced ...

UPPER MICHIGAN (WLUC) - An estimated $3.1 billion is expected to be legally wagered on the men’s and women’s college ...

Untangling the functional organisation of a brain region crucial for memory and learning helps reveal how individual differences are linked to variations in recall ability, aging and dopamine receptor ...

For the first time, scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility, according to new research published in the March issue of The Journal of Nuclear ...

A study published Wednesday indicates that low levels of a key brain chemical among overweight patients with high-fat diets ...

Discover eight ways your diet and lifestyle directly influence neurotransmitter balance, affecting mood, focus, sleep quality and cognitive function.